Načítá se...
Low molecular weight heparin for the prevention of severe preeclampsia: where next?
Low molecular weight heparin has been extensively evaluated for the prevention of preeclampsia in high‐risk pregnant women; however, the results from these trials have been conflicting. This review discusses the potential mechanisms of action of low molecular weight heparin for the prevention of sev...
Uloženo v:
| Vydáno v: | Br J Clin Pharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867115/ https://ncbi.nlm.nih.gov/pubmed/29226532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13483 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|